Generation Bio Co (NASDAQ:GBIO) does about 703.21K shares in volume on a normal day but saw 4113421 shares change hands in the recent trading day. The company now has a market cap of 21.46M USD. Its current market price is $0.32, marking an increase of 6.56% compared to the previous close of $0.3. The 52 week high reached by this stock is $3.65 whilst the lowest price level in 52 weeks is $0.30.
The consensus objective for the share price is $6.50, suggesting that the stock has a potential upside of 95.08% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is -14.97%, -17.82%, and -70.40% away from its SMA20, SMA50, and SMA200 respectively, with the GBIO price moving above the 50-day SMA on current market day. Generation Bio Co (GBIO) stock is down -11.06% over the week and -17.54% over the past month. Its price is -88.57% year-to-date and -69.80% over the past year.
To reach the target analysts have set, the stock logically needs to grow 95.08 percent from here.
Outstanding shares total 67.01M with insiders holding 14.37% of the shares and institutional holders owning 72.37% of the company’s common stock. The company has a return on investment of -47.49% and return on equity of -70.06%. The beta has a value of 2.59. Price to book ratio is 0.29 and price to sales ratio is 0.87.
